These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31182918)

  • 21. Protective effects of cichoric acid on H
    Ma J; Li M; Kalavagunta PK; Li J; He Q; Zhang Y; Ahmad O; Yin H; Wang T; Shang J
    Biomed Pharmacother; 2018 Aug; 104():679-685. PubMed ID: 29803928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
    Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
    Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
    Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
    J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
    Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
    Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
    Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs.
    Dai W; Wang K; Zheng X; Chen X; Zhang W; Zhang Y; Hou J; Liu L
    Nutr Metab (Lond); 2015; 12():42. PubMed ID: 26583037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
    Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
    Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis.
    Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Krag A; Karsdal MA; Nielsen MJ; Brockbank S; Cruwys S
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G410-G418. PubMed ID: 31905026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of triggering receptor expressed on myeloid cells 2-associated alterations on lipid metabolism in macrophages in the development of non-alcoholic fatty liver disease.
    Ji PX; Chen YX; Ni XX; Miao Q; Hua J
    J Gastroenterol Hepatol; 2024 Feb; 39(2):369-380. PubMed ID: 38012119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver Disease.
    Fengler VH; Macheiner T; Kessler SM; Czepukojc B; Gemperlein K; Müller R; Kiemer AK; Magnes C; Haybaeck J; Lackner C; Sargsyan K
    PLoS One; 2016; 11(5):e0155163. PubMed ID: 27167736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats.
    Ma Z; Chu L; Liu H; Wang W; Li J; Yao W; Yi J; Gao Y
    Sci Rep; 2017 Mar; 7():44819. PubMed ID: 28300221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine.
    Grasselli E; Canesi L; Portincasa P; Voci A; Vergani L; Demori I
    Ann Hepatol; 2017; 16(5):707-719. PubMed ID: 28809727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaempferol-3-O-Glucuronide Ameliorates Non-Alcoholic Steatohepatitis in High-Cholesterol-Diet-Induced Larval Zebrafish and HepG2 Cell Models via Regulating Oxidation Stress.
    Deng Y; Ma J; Weng X; Wang Y; Li M; Yang T; Dou Z; Yin Z; Shang J
    Life (Basel); 2021 May; 11(5):. PubMed ID: 34069176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired learning and memory in rats induced by a high-fat diet: Involvement with the imbalance of nesfatin-1 abundance and copine 6 expression.
    Chen Z; Xu YY; Wu R; Han YX; Yu Y; Ge JF; Chen FH
    J Neuroendocrinol; 2017 Apr; 29(4):. PubMed ID: 28211103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease.
    Zhang H; Léveillé M; Courty E; Gunes A; N Nguyen B; Estall JL
    Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E863-E876. PubMed ID: 32924526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of a novel non‑alcoholic fatty liver disease model using cholesterol‑fed rabbits with reference to the potential role of endoplasmic reticulum stress.
    Wang Y; Zhang P; Su X; Yu Q; Chen Y; Guan H; Liu E; Fan J
    Mol Med Rep; 2018 Sep; 18(3):2898-2904. PubMed ID: 30015906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis.
    Ye H; Ma S; Qiu Z; Huang S; Deng G; Li Y; Xu S; Yang M; Shi H; Wu C; Li M; Zhang J; Zhang F; Qin M; Huang H; Zeng Z; Wang M; Chen Y; Lin H; Gao Z; Cai M; Song Y; Gong S; Gao L
    J Ethnopharmacol; 2022 Oct; 296():115457. PubMed ID: 35753609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
    He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
    World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.